SCHEMBL18018251

SCHEMBL18018251

CC(C)(C)OC(=O)N1[C@H](CO)CCC12CC2

nearest known ligand 0.42

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ NR1H2 P55055 1/20 0.41
▸ CHRM2 P08172 1/20 0.37
▸ CHRM1 P11229 1/20 0.37
▸ CHRM3 P20309 1/20 0.37
▸ DDB1 Q16531 2/20 0.35
▸ CRBN Q96SW2 2/20 0.35
▸ HPGD P15428 1/20 0.34
▸ SPHK1 Q9NYA1 1/20 0.33
▸ KDM1A O60341 1/20 0.33
▸ KDM4E B2RXH2 1/20 0.33
▸ MAPT P10636 1/20 0.33
▸ THRB P10828 1/20 0.33
▸ RECQL P46063 1/20 0.33
▸ EPHX1 P07099 1/20 0.33
▸ CTSK P43235 1/20 0.33
▸ USP2 O75604 1/20 0.33
▸ SMN1; SMN2 Q16637 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31421521 1.00 NR1H2 (0.41) NR1H2CHRM2CHRM1CHRM3DDB1
SCHEMBL21441794 1.00 NR1H2 (0.41) NR1H2CHRM2CHRM1CHRM3DDB1
SCHEMBL19637550 0.84 NR1H2 (0.41) NR1H2CHRM2CHRM1CHRM3DDB1
SCHEMBL13606646 0.84 NR1H2 (0.41) NR1H2CHRM2CHRM1CHRM3DDB1
SCHEMBL19959327 0.84 NR1H2 (0.41) NR1H2CHRM2CHRM1CHRM3DDB1
SCHEMBL31420833 0.84 CHRM2 (0.35) NR1H2CHRM2CHRM1CHRM3DDB1
SCHEMBL31421605 0.84 CHRM2 (0.35) NR1H2CHRM2CHRM1CHRM3DDB1
SCHEMBL31421279 0.84 MEN1 (0.40) NR1H2CHRM2CHRM1CHRM3DDB1
SCHEMBL31420587 0.84 MEN1 (0.40) NR1H2CHRM2CHRM1CHRM3DDB1
SCHEMBL15786676 0.83 NR1H2 (0.40) NR1H2CHRM2CHRM1CHRM3DDB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250129021-A1 SMALL MOLECULE PROTEIN SYNTHESIS MODULATORS Interdict Bio, Inc. (US) 2025-04-24 — — US disclosed
WO-2025064718-A1 SMALL MOLECULE PROTEIN SYNTHESIS MODULATORS Interdict Bio, Inc. (US) 2025-03-27 — — WO disclosed
CN-112209933-B BTK inhibitors containing 4-azacycloheptane 正大天晴药业集团股份有限公司 2023-09-08 — — CN disclosed
CN-107922392-B 1- (hetero) arylsulfonyl- (pyrrolidine or piperidine) -2-carboxamide derivatives and uses thereof 豪夫迈·罗氏有限公司 2020-07-21 — — CN disclosed
EP-3256463-B1 1-(HET)ARYLSULFONYL-(PYRROLIDINE OR PIPERIDINE)-2-CARBOXAMIDE DERIVATIVES AND THEIR USE AS TRPA1 ANTAGONISTS HOFFMANN LA ROCHE (CH) 2019-10-09 — — EP disclosed
US-10179782-B2 Substituted sulfonamide compounds GENENTECH, INC. (US) 2019-01-15 — — US disclosed
US-20160264567-A1 SUBSTITUTED SULFONAMIDE COMPOUNDS GENENTECH, INC. (US) 2016-09-15 — — US disclosed
US-20160264567-A1 SUBSTITUTED SULFONAMIDE COMPOUNDS GENENTECH, INC. (US) 2016-09-15 — — US disclosed
WO-2016128529-A1 1-(HET)ARYLSULFONYL-(PYRROLIDINE OR PIPERIDINE)-2-CARBOXAMIDE DERIVATIVES AND THEIR USE AS TRPA1 ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2016-08-18 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10179782-B2 Substituted sulfonamide compounds TRPA1, TRPV1, TRPV5 NR1H2 1032/4885CHRM2 1678/4885CHRM1 2358/4885
US-20250129021-A1 SMALL MOLECULE PROTEIN SYNTHESIS MODULATORS MYC, KRAS, NRAS NR1H2 2741/4885CHRM2 4776/4885CHRM1 4803/4885
US-20160264567-A1 SUBSTITUTED SULFONAMIDE COMPOUNDS TRPA1, TRPV1, TRPV5 NR1H2 1032/4885CHRM2 1678/4885CHRM1 2358/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback